Rates and Determinants of Eyecare Utilization and Eyeglass Affordability Among Individuals With Visual Impairment in a Multi-Ethnic Population-Based Study in Singapore.
Asians
eyecare utilization
spectacle affordability
visual impairment
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
08
10
2019
accepted:
24
02
2020
entrez:
22
8
2020
pubmed:
22
8
2020
medline:
22
8
2020
Statut:
epublish
Résumé
The purpose of this study was to determine the rates of, and factors associated with, eyecare utilization and spectacle affordability among Singaporeans with vision impairment (VI). We included adults with VI from their second visit of the Singapore Epidemiology of Eye Disease Study. Data on eyecare utilization and spectacle affordability were collected. Low eyecare utilization was defined as no eye check ever or eye checks not even once per year in reference to at least once per year. Difficulty affording glasses was defined as glasses being rated as expensive in reference to not expensive. There were 985 adults (14.5%; 415 Malays, 260 Indian, and 310 Chinese; mean age [SD]: 69.5 [10.2] years; 55.4% women) with VI who answered the above questions, were included. Of these, 624 (63.4%) wore glasses. The rates of low eyecare utilization and difficulty affording eyeglasses were 31% and 63%, respectively. Compared to Chinese (23.8%) and Indians (18.8%), Malays (57.4%) had the highest rates of low eyecare utilization ( In this multi-ethnic population with VI, almost one-third had low eyecare utilization and nearly two-thirds reported difficulty affording eyeglasses. This will inform strategies, such as tailored eyecare utilization awareness campaigns and awareness of available subsidy schemes for at-risk Singaporeans, such as Malays.
Identifiants
pubmed: 32821483
doi: 10.1167/tvst.9.5.11
pii: TVST-19-2030
pmc: PMC7401894
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
11Informations de copyright
Copyright 2020 The Authors.
Déclaration de conflit d'intérêts
Disclosure: P. Gupta, None; S. Majithia, None; E.K. Fenwick, None; A.T.L. Gan, None; Y.-C. Tham, None; S. Poh, None; S. Thakur, None; C. Sabanayagam, None; T.Y. Wong, None; C.-Y. Cheng, None; E.L. Lamoureux, None
Références
Ophthalmology. 2011 Sep;118(9):1798-804
pubmed: 21621261
Ophthalmic Epidemiol. 2008 Nov-Dec;15(6):418-25
pubmed: 19065435
Trans Am Ophthalmol Soc. 2004;102:47-54; discussion 54-5
pubmed: 15747744
Ophthalmology. 2014 Oct;121(10):2013-22
pubmed: 24950592
Ophthalmology. 2013 Feb;120(2):415-22
pubmed: 23149127
Psychol Health. 2000 Nov;14(6):965-77
pubmed: 22175256
Ophthalmic Epidemiol. 2009 Nov-Dec;16(6):325-36
pubmed: 19995197
BMC Ophthalmol. 2006 Jan 20;6:4
pubmed: 16423308
JAMA Ophthalmol. 2015 Aug;133(8):938-46
pubmed: 26043441
Ophthalmology. 2010 Sep;117(9):1755-62
pubmed: 20471689
Arch Ophthalmol. 2008 Aug;126(8):1091-9
pubmed: 18695104
Aust N Z J Ophthalmol. 1999 Oct;27(5):294-300
pubmed: 10571388
Arch Ophthalmol. 2008 Aug;126(8):1121-6
pubmed: 18695107
JAMA Ophthalmol. 2019 Apr 1;137(4):391-398
pubmed: 30676634
Br J Ophthalmol. 2015 Dec;99(12):1614-21
pubmed: 25953847
Invest Ophthalmol Vis Sci. 2013 Apr 09;54(4):2590-8
pubmed: 23513059
Sci Rep. 2018 Aug 15;8(1):12224
pubmed: 30111785
J Health Psychol. 1996 Apr;1(2):209-22
pubmed: 22011705
JAMA Ophthalmol. 2013 Sep;131(9):1198-206
pubmed: 23868137
Int J Equity Health. 2018 Apr 02;17(1):39
pubmed: 29609592
Br J Ophthalmol. 2004 Oct;88(10):1237-41
pubmed: 15377541
Optom Vis Sci. 2014 Feb;91(2):212-20
pubmed: 24270637
Clin Exp Ophthalmol. 2012 Aug;40(6):557-68
pubmed: 22300454
PLoS One. 2017 Jan 27;12(1):e0170804
pubmed: 28129358
Diabetes Care. 2015 Jan;38 Suppl:S4
pubmed: 25537706
Am J Ophthalmol. 2017 Oct;182:18-30
pubmed: 28734819
Can J Ophthalmol. 2011 Apr;46(2):133-8
pubmed: 21708079
Ophthalmology. 2008 Nov;115(11):1973-81
pubmed: 18584873
Health Serv Res. 2018 Dec;53(6):4332-4352
pubmed: 29770438
Arch Ophthalmol. 2007 Mar;125(3):411-8
pubmed: 17353417
BMC Public Health. 2007 Jul 27;7:184
pubmed: 17655774
Diabetes Res Clin Pract. 2016 Oct;120:241-3
pubmed: 27667395
Curr Eye Res. 2010 Jun;35(6):451-8
pubmed: 20465437
Am J Public Health. 1998 Aug;88(8):1225-9
pubmed: 9702155
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):72-82
pubmed: 9008632
Clin Exp Ophthalmol. 2017 Nov;45(8):779-789
pubmed: 28472538
Ophthalmic Epidemiol. 2007 Jan-Feb;14(1):25-35
pubmed: 17365815
Med Care. 2000 Jun;38(6):638-46
pubmed: 10843311
Health Serv Res. 1995 Apr;30(1 Pt 2):179-95
pubmed: 7721591
Ann Acad Med Singapore. 2015 Sep;44(9):326-34
pubmed: 26584661
Arch Ophthalmol. 2009 Mar;127(3):303-10
pubmed: 19273794
Am J Ophthalmol. 2012 Dec;154(6 Suppl):S45-52.e1
pubmed: 23158223
Ophthalmology. 2013 Jul;120(7):1497-501
pubmed: 23511113
BMJ Open Ophthalmol. 2018 Sep 1;3(1):e000135
pubmed: 30246151
Ophthalmic Epidemiol. 2005 Feb;12(1):1-12
pubmed: 15848915
Ophthalmology. 2014 Sep;121(9):1837-42
pubmed: 24768238
Health Policy. 2016 Jun;120(6):638-45
pubmed: 27025977
BMJ Open. 2013 Nov 07;3(11):e003471
pubmed: 24202057
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
Ophthalmology. 2018 Apr;125(4):529-536
pubmed: 29217148
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2614-20
pubmed: 19470808